Addex Therapeutics (GB:0QNV) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Addex Therapeutics has released its unaudited interim condensed consolidated financial statements for the first half of 2024, showing total assets of CHF 13.7 million as of June 30, compared to CHF 4.6 million at the end of the previous year. The financials indicate an increase in total equity to CHF 12.65 million from CHF 1.14 million, with a reported revenue from contracts with customers totaling CHF 115,277 for the three-month period ending June 30, 2024.
For further insights into GB:0QNV stock, check out TipRanks’ Stock Analysis page.
